Dysregulated Dscam levels act through Abelson tyrosine kinase to enlarge presynaptic arbors

Increased expression of Down Syndrome Cell Adhesion Molecule (Dscam) is implicated in the pathogenesis of brain disorders such as Down syndrome (DS) and fragile X syndrome (FXS). Here, we show that the cellular defects caused by dysregulated Dscam levels can be ameliorated by genetic and pharmacolog...

Full description

Bibliographic Details
Main Authors: Gabriella R Sterne, Jung Hwan Kim, Bing Ye
Format: Article
Language:English
Published: eLife Sciences Publications Ltd 2015-05-01
Series:eLife
Subjects:
Online Access:https://elifesciences.org/articles/05196
_version_ 1811201089696956416
author Gabriella R Sterne
Jung Hwan Kim
Bing Ye
author_facet Gabriella R Sterne
Jung Hwan Kim
Bing Ye
author_sort Gabriella R Sterne
collection DOAJ
description Increased expression of Down Syndrome Cell Adhesion Molecule (Dscam) is implicated in the pathogenesis of brain disorders such as Down syndrome (DS) and fragile X syndrome (FXS). Here, we show that the cellular defects caused by dysregulated Dscam levels can be ameliorated by genetic and pharmacological inhibition of Abelson kinase (Abl) both in Dscam-overexpressing neurons and in a Drosophila model of fragile X syndrome. This study offers Abl as a potential therapeutic target for treating brain disorders associated with dysregulated Dscam expression.
first_indexed 2024-04-12T02:15:01Z
format Article
id doaj.art-caf56b3cac0d4b5db9108de267d8e41a
institution Directory Open Access Journal
issn 2050-084X
language English
last_indexed 2024-04-12T02:15:01Z
publishDate 2015-05-01
publisher eLife Sciences Publications Ltd
record_format Article
series eLife
spelling doaj.art-caf56b3cac0d4b5db9108de267d8e41a2022-12-22T03:52:17ZengeLife Sciences Publications LtdeLife2050-084X2015-05-01410.7554/eLife.05196Dysregulated Dscam levels act through Abelson tyrosine kinase to enlarge presynaptic arborsGabriella R Sterne0Jung Hwan Kim1Bing Ye2Life Sciences Institute, University of Michigan, Ann Arbor, United States; Department of Cell and Developmental Biology, University of Michigan, Ann Arbor, United StatesLife Sciences Institute, University of Michigan, Ann Arbor, United States; Department of Cell and Developmental Biology, University of Michigan, Ann Arbor, United StatesLife Sciences Institute, University of Michigan, Ann Arbor, United States; Department of Cell and Developmental Biology, University of Michigan, Ann Arbor, United StatesIncreased expression of Down Syndrome Cell Adhesion Molecule (Dscam) is implicated in the pathogenesis of brain disorders such as Down syndrome (DS) and fragile X syndrome (FXS). Here, we show that the cellular defects caused by dysregulated Dscam levels can be ameliorated by genetic and pharmacological inhibition of Abelson kinase (Abl) both in Dscam-overexpressing neurons and in a Drosophila model of fragile X syndrome. This study offers Abl as a potential therapeutic target for treating brain disorders associated with dysregulated Dscam expression.https://elifesciences.org/articles/05196DscamAblfragile X syndrometyrosine kinase inhibitorpresynaptic terminalneuronal development
spellingShingle Gabriella R Sterne
Jung Hwan Kim
Bing Ye
Dysregulated Dscam levels act through Abelson tyrosine kinase to enlarge presynaptic arbors
eLife
Dscam
Abl
fragile X syndrome
tyrosine kinase inhibitor
presynaptic terminal
neuronal development
title Dysregulated Dscam levels act through Abelson tyrosine kinase to enlarge presynaptic arbors
title_full Dysregulated Dscam levels act through Abelson tyrosine kinase to enlarge presynaptic arbors
title_fullStr Dysregulated Dscam levels act through Abelson tyrosine kinase to enlarge presynaptic arbors
title_full_unstemmed Dysregulated Dscam levels act through Abelson tyrosine kinase to enlarge presynaptic arbors
title_short Dysregulated Dscam levels act through Abelson tyrosine kinase to enlarge presynaptic arbors
title_sort dysregulated dscam levels act through abelson tyrosine kinase to enlarge presynaptic arbors
topic Dscam
Abl
fragile X syndrome
tyrosine kinase inhibitor
presynaptic terminal
neuronal development
url https://elifesciences.org/articles/05196
work_keys_str_mv AT gabriellarsterne dysregulateddscamlevelsactthroughabelsontyrosinekinasetoenlargepresynapticarbors
AT junghwankim dysregulateddscamlevelsactthroughabelsontyrosinekinasetoenlargepresynapticarbors
AT bingye dysregulateddscamlevelsactthroughabelsontyrosinekinasetoenlargepresynapticarbors